dc.creatorAbruzzese, Giselle Adriana
dc.creatorCrisosto, Nicolás
dc.creatorDe Grava Kempinas, Wilma
dc.creatorSotomayor Zárate, Ramón
dc.date.accessioned2019-10-24T18:20:22Z
dc.date.accessioned2022-10-15T03:27:45Z
dc.date.available2019-10-24T18:20:22Z
dc.date.available2022-10-15T03:27:45Z
dc.date.created2019-10-24T18:20:22Z
dc.date.issued2018-10
dc.identifierAbruzzese, Giselle Adriana; Crisosto, Nicolás; De Grava Kempinas, Wilma; Sotomayor Zárate, Ramón; Developmental programming of the female neuroendocrine system by steroids; Wiley Blackwell Publishing, Inc; Journal of Neuroendocrinology; 30; 10; 10-2018; 1-31
dc.identifier0953-8194
dc.identifierhttp://hdl.handle.net/11336/87234
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4340052
dc.description.abstractDevelopmental programming refers to processes that occur during early life that may have long-term consequences, modulating adult health and disease. Complex diseases, such as diabetes, cancer and cardiovascular disease, have a high prevalence in different populations, are multifactorial, and may have a strong environmental component. The environment interacts with organisms, affecting their behaviour, morphology and physiology. This interaction may induce permanent or long-term changes, and organisms may be more susceptible to environmental factors during certain developmental stages, such as the prenatal and early postnatal periods. Several factors have been identified as responsible for inducing the reprogramming of various reproductive and nonreproductive tissues. Among them, both natural and synthetic steroids, such as endocrine disruptors, are known to have either detrimental or positive effects on organisms depending on the dose of exposure, stage of development and biological sexual background. The present review focuses on the action of steroids and endocrine disruptors as agents involved in developmental programming and on their modulation and effects on female neuroendocrine functions.
dc.languageeng
dc.publisherWiley Blackwell Publishing, Inc
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://doi.wiley.com/10.1111/jne.12632
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/jne.12632
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDEVELOPMENTAL PROGRAMMING
dc.subjectENDOCRINE DISRUPTORS
dc.subjectGLUCOCORTICOIDS
dc.subjectGONADAL STEROIDS
dc.titleDevelopmental programming of the female neuroendocrine system by steroids
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución